Drug Shortage Report for CLINDAMYCIN INJECTION USP
| Report ID | 147917 |
| Drug Identification Number | 02230540 |
| Brand name | CLINDAMYCIN INJECTION USP |
| Common or Proper name | CLINDAMYCIN INJ |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CLINDAMYCIN |
| Strength(s) | 150MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 2ML 10LIVI |
| ATC code | J01FF |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2021-10-25 |
| Estimated end date | 2021-11-26 |
| Actual end date | 2021-11-24 |
| Shortage status | Resolved |
| Updated date | 2021-11-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-11-24 | French | Compare |
| v6 | 2021-11-24 | English | Compare |
| v5 | 2021-11-03 | French | Compare |
| v4 | 2021-11-03 | English | Compare |
| v3 | 2021-10-26 | English | Compare |
| v2 | 2021-10-25 | French | Compare |
| v1 | 2021-10-25 | English | Compare |
Showing 1 to 7 of 7